3654 results for «370»

Filter By

3654 results

TAVI in a grey zone - Part 2

28 Apr 2021 – From EuroPCR 2021

Thanks to this session, study TAVI in case of Fabry disease, analyze severe aortic valve stenosis with cardiogenic shock requiring ECMO, get the chance to examine TAVI in challenging valve position with calcified aortic valve, and much more!

EuroPCR 2021 - TAVI in a grey zone - Part 2

Challenging scenarios in STEMI patients

14 Apr 2021 – From EuroPCR 2021

In this session, you'll discover challenging STEMI cases: STEMI with cardiogenic shock and no vascular access for mechanical support, anterior STEMI with critical LMCA stenosis, double culprits STEMI, and much more!

EuroPCR 2021 Challenging scenarios in STEMI patients

Stent dislodgement / Fracture - Part 2

14 Apr 2021 – From EuroPCR 2021

This session will help you learn more about bail out strategies in case of stent fracture, especially when facing calcified lesions, analyze post left main stenting sparkle in aorta, find out more about floating left anterior descending artery stents, and more!

EuroPCR 2021 Stent dislodgement / Fracture - Part 2

Percutaneous treatment of tricuspid regurgitation in 2021 - part 1

28 Apr 2021 – From EuroPCR 2021

This session will enable you to find out more about refractory heart failure in severe stand-alone tricuspid regurgitation, to study the one-shot transcatheter solution for torrential tricuspid regurgitation, and to witness full percutaneous three in one.

EuroPCR 2021 Percutaneous treatment of tricuspid regurgitation in 2021 - part 1

Coronary dissection - Part 1

28 Apr 2021 – From EuroPCR 2021

This session will help you know how to manage an iatrogenic intramural haematoma, how to treat a large pseudoaneurysm following PCI in SCAD, how to dissect flow-limiting spontaneous coronary, and much more!

EuroPCR 2021 Coronary dissection - Part 1

Complex PCI in complex patients

28 Apr 2021 – From EuroPCR 2021

Watch this session to learn more about various existing ways to treat the culprit vessel during TAVI, double CTO on ECMO following in-hospital cardiac arrest, acute ST-elevation myocardial infarction and heavily calcified lesion, STEMI and cardiogenic shock, and more!

EuroPCR 2021 Complex PCI in complex patients

Treatment of bifurcation lesions

28 Apr 2021 – From EuroPCR 2021

This session will enable you to appreciate double kissing culotte for distal left main bifurcation, compare shotgun stenting vs complex PCI techniques in elderly patients, view critical distal left main stenosis and jailed wire, and much more!

EuroPCR 2021 Treatment of bifurcation lesions

Calcified arteries: rotablation, lithotripsy or both? - Part 1

28 Apr 2021 – From EuroPCR 2021

Thanks to this session, you will discover the contemporary ROTA-SHOCK-PUMP approach, compare traditional and innovative techniques to treat severe calcified stenosis, learn how to handle a coronary lithotripsy after rotational atherectomy in the presence of haematoma, and much more!

EuroPCR 2021 Calcified arteries: rotablation, lithotripsy or both? - Part 1

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening

PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

07 Nov 2021

Professor David J. Cohen presented the results of the economic outcomes of the PARTNER 3 trial on Friday, 5 November, in the Late-Breaking Trial session of the Transcatheter Cardiovascular Therapeutics Congress 2021. Giuseppe Biondi-Zoccai provides his analysis of this study.

Giuseppe Biondi Zoccai

Author

Giuseppe Biondi-Zoccai
PARTNER 3: weighing the comparative costs and savings of TAVI versus SAVR in low-risk patients with severe aortic stenosis

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Nicola Ryan

Author

Nicola Ryan
RESHAPE-HF2

The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

05 Sep 2023

The 2023 European Society of Hypertension (ESH) guidelines were recently presented at the 32nd annual European Meeting on Hypertension and Cardiovascular Protection and simultaneously published in the Journal of Hypertension.1 While wide parts of the guidelines do not substantially differ from the previous 2018 European Society...

Lucas Lauder

Author

Lucas Lauder

Author

Felix Mahfoud
The 2023 ESH Hypertension Guidelines revisit the role of renal denervation

3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

22 Mar 2022

Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.

Ali Nazmi Calik

Author

Ali Nazmi Calik
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications

Transfemoral TAVI in the horizontal aorta

12 May 2020

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.

Transfemoral TAVI in the horizontal aorta
Didn’t find what you were looking for?